These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3602051)

  • 1. [The effect of inhibitors on phenylbutazone oxidation--comparison of rapid tests of dosage forms].
    Kühn H
    Pharmazie; 1987 Feb; 42(2):127-8. PubMed ID: 3602051
    [No Abstract]   [Full Text] [Related]  

  • 2. [Analysis of multicomponent drug mixtures by the method of chromatography on thin loose layers of aluminum oxide].
    Slepova LN; Moldaver BL; Khaletskiĭ AM
    Farmatsiia; 1969; 18(4):48-51. PubMed ID: 5379652
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of auto-oxidation by ascorbic acid esters. 3. Evidenced by thin layer chromatography of some liposuloble antioxidant agents incorporated in some glycerdies and some galenic preparations].
    Schorderet M; Kapétanidis I
    Pharm Acta Helv; 1967 Jun; 42(6):350-6. PubMed ID: 5602003
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of azobenzene by thin-layer chromatography in pharmaceutical preparations containing phenylbutazone.
    Santoro MI; Gremião MP; Hackmann ER; Magalhães JF
    Pharmazie; 1985 Oct; 40(10):729-30. PubMed ID: 4080790
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of phenylbutazone by acid hydrolysis and permanganometric oxidation] [Hun.
    Vinkler E; Stájer G
    Acta Pharm Hung; 1968; 38(4):273-8. PubMed ID: 5682208
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination and thin-layer chromatography of phenylbutazone in the presence of decomposition products.
    Beckstead HD; Kaistha KK; Smith SJ
    J Pharm Sci; 1968 Nov; 57(11):1952-7. PubMed ID: 5725928
    [No Abstract]   [Full Text] [Related]  

  • 7. Application of Henderson equation for the determination of weakly acidic pharmaceutical compounds. Part 3: Determination of phenylbutazone.
    El-Fatatry HM; Sharafel-Deen MM; Amer MM
    Pharmazie; 1979; 34(3):155-7. PubMed ID: 450955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thin layer chromatography of derivatives of pyrazolone].
    Sarsúnová M; Kakác B
    Pharmazie; 1972 Jul; 27(7):447-8. PubMed ID: 5087238
    [No Abstract]   [Full Text] [Related]  

  • 9. [Method for the determination of phenylbutazone (FB) following chromatographic separation from isopyrine hydrochloride (I) and their decomposition production].
    Gołucki Z; Kobylińska-Luczko A
    Acta Pol Pharm; 1978; 35(2):233-6. PubMed ID: 665278
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the identification reactions of phenylbutazone].
    Vinkler E; Stájer G
    Pharmazie; 1969 Jan; 24(1):42-5. PubMed ID: 5771399
    [No Abstract]   [Full Text] [Related]  

  • 11. Quality control of phenylbutazone I: Analysis of phenylbutazone and decomposition products in drugs by TLC.
    Fabre H; Mandrou B
    J Pharm Sci; 1981 Apr; 70(4):460-1. PubMed ID: 7229969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Spectrophotometric analysis of phenylbutazone and aminopyrine in mixtures].
    Bagnarelli AE
    Rev Sanid Milit Argent; 1966; 65(1):92-8. PubMed ID: 5986739
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sprectrophotometry of phenylbutazone].
    Magalhães JF; Piros MG
    Rev Farm Bioquim Univ Sao Paulo; 1973; 11(1):41-50. PubMed ID: 4789381
    [No Abstract]   [Full Text] [Related]  

  • 14. Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.
    Lewis RJ; Trager WF; Chan KK; Breckenridge A; Orme M; Roland M; Schary W
    J Clin Invest; 1974 Jun; 53(6):1607-17. PubMed ID: 4830225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Auto-oxidation in dermopharmaceutical preparations. A proposed method for the identification of anti-oxidants by thin-layer-chromatography (author's transl)].
    Dooms-Goossens A
    J Pharm Belg; 1977; 32(3):213-28. PubMed ID: 894480
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thin-layer chromatography of 1-phenyl-4n-butyl-3,5-dioxopyrazolidine (Monophenylbutazone)].
    Salzmann U
    Pharm Acta Helv; 1971 Dec; 46(12):721-9. PubMed ID: 5143003
    [No Abstract]   [Full Text] [Related]  

  • 17. [New drugs in the 3d edition of the Czechoslovak Pharmacopoeia and their determination. II. Chromatographic and spectrophotometric determination of ketophenylbutazone].
    Citovická N; Faith L
    Cesk Farm; 1970 May; 19(4):126-32. PubMed ID: 5448540
    [No Abstract]   [Full Text] [Related]  

  • 18. [Detection and characterization of several drugs derived from purine by thin layer chromatography].
    Poey J; Denine R; Merad-Boudia R; Mrabet N
    Eur J Toxicol; 1971; 4(4):341-4. PubMed ID: 5150094
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification and determination of beta-diketones present in drugs. I. Identification by thin-layer chromatography method.
    Pomazańska-Kolodziejska
    Acta Pol Pharm; 1972; 29(4):395-8. PubMed ID: 4652511
    [No Abstract]   [Full Text] [Related]  

  • 20. Voltammetric determination of coenzyme Q10 in pharmaceutical dosage forms.
    Michalkiewicz S
    Bioelectrochemistry; 2008 Jun; 73(1):30-6. PubMed ID: 18495552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.